Literature DB >> 30497048

Fatal poisoning involving cyclopropylfentanyl - Investigation of time-dependent postmortem redistribution.

Lana Brockbals1, Sandra N Staeheli1, Simon Gentile2, Markus Schlaepfer3, Christian Bissig3, Stephan A Bolliger2, Thomas Kraemer1, Andrea E Steuer4.   

Abstract

A growing number of fatal overdoses involving opioid drugs, in particular involving fentanyl and its analogues, pose an immense threat to public health. Postmortem casework of forensic toxicologists in such cases is challenging, as data on pharmacodynamic and pharmacokinetic properties as well as reference values for acute toxicities and data on potential postmortem redistribution (PMR) mechanisms often do not exist. A fatal case involving cyclopropylfentanyl was investigated at the Zurich Institute of Forensic Medicine and the Zurich Forensic Science Institute; an unknown powder found at the scene was reliably identified as cyclopropylfentanyl by gas chromatography-infrared spectroscopy (GC-IR). Femoral blood samples were collected at two time points after death; 11h postmortem (t1) and during the medico-legal autopsy 29h after death (t2). At the autopsy, additional samples from the heart blood, urine and gastric content were collected. Cyclopropylfentanyl was quantified using a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. Femoral blood concentration of cyclopropylfentanyl at autopsy was 19.8ng/mL (t1=15.7ng/mL; heart blood concentration at autopsy=52.4ng/mL). In the light of the current literature and under the exclusion that no other morphological findings could explain the cause of death, contribution of cyclopropylfentanyl to death was proposed (polydrug use). Significant postmortem concentration increases of cyclopropylfentanyl in femoral blood during 18h after the first sampling were observed, thus indicating a relevant potential to undergo PMR. A central-to-peripheral blood concentration ratio of 2.6 supports this. Consequently, the current case suggests that postmortem cyclopropylfentanyl concentration should always be interpreted with care.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative matrices; Cyclopropylfentanyl; Fentanyl analogue; LC–MS/MS; Time-dependent postmortem redistribution

Mesh:

Substances:

Year:  2018        PMID: 30497048     DOI: 10.1016/j.forsciint.2018.11.007

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  6 in total

Review 1.  Interpol review of toxicology 2016-2019.

Authors:  Wing-Sum Chan; George Fai Wong; Chi-Wai Hung; Yau-Nga Wong; Kit-Mai Fung; Wai-Kit Lee; Kwok-Leung Dao; Chung-Wing Leung; Kam-Moon Lo; Wing-Man Lee; Bobbie Kwok-Keung Cheung
Journal:  Forensic Sci Int       Date:  2020-05-23       Impact factor: 2.395

Review 2.  Blood concentrations of new synthetic opioids.

Authors:  Piotr Adamowicz; Karolina Nowak
Journal:  Int J Legal Med       Date:  2021-10-22       Impact factor: 2.686

Review 3.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.

Authors:  Amanda L A Mohr; Barry K Logan; Melissa F Fogarty; Alex J Krotulski; Donna M Papsun; Sherri L Kacinko; Marilyn A Huestis; Jeri D Ropero-Miller
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

4.  Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats.

Authors:  Marianne Skov-Skov Bergh; Inger Lise Bogen; Nancy Garibay; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2021-10-06       Impact factor: 4.415

Review 5.  Causes, Nature and Toxicology of Fentanyl-Analogues Associated Fatalities: A Systematic Review of Case Reports and Case Series.

Authors:  Umaani Rauf; Majid Ali; Inderpal Dehele; Vibhu Paudyal; Mohamed Hassan Elnaem; Ejaz Cheema
Journal:  J Pain Res       Date:  2021-08-24       Impact factor: 3.133

6.  Activation of the μ-opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure.

Authors:  Anna Åstrand; Svante Vikingsson; Ingrid Jakobsen; Niclas Björn; Robert Kronstrand; Henrik Gréen
Journal:  Drug Test Anal       Date:  2020-08-14       Impact factor: 3.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.